Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Summer Sessions 4: Dr. Loretta Itri On Taking ADCs Across The Finish Line

    Summer Sessions 4: Dr. Loretta Itri On Taking ADCs Across The Finish Line

    FromBusiness Of Biotech

    Start listeningView podcast show

    Summer Sessions 4: Dr. Loretta Itri On Taking ADCs Across The Finish Line

    FromBusiness Of Biotech

    ratings:
    Length:
    41 minutes
    Released:
    Aug 3, 2020
    Format:
    Podcast episode

    Description

    While Immunomedics CMO Loretta Itri, M.D. is no stranger to taking drugs across the commercial finish line in big pharma, her most recent win with TRODELVY was very, very different. Here, Dr. Itri shares insight on her small biopharma's first commercial launch, the manufacturing and regulatory challenges overcome to get there, and why ADCs are coming of age.
    Released:
    Aug 3, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.